GFAP is a 52-kDa antigen, the main intermediate filament protein in mature astrocytes, that was targeted in 44% of the AMD patients’ population studied [17]; however, we have not found AAbs against 52-kDa antigen in a measurable level in our cohort. Here, GFAP is linked to age-related macular degeneration.